CHRNA7 and HIV-associated neurocognitive disorder: In conclusion, our vitro study revealed that KYNA blocks a7nAChR/NF-κB signaling activation to promote A2 astrocyte formation and ameliorates neuropathological deficits of HAND by attenuating glutamate toxicity and secreting neurotrophic factors.